glp 1 based therapy for diabetes The Benefits of GLP-1 Therapy: Beyond Weight Loss GIPR/GLP-1R dual agonist therapies for

(2025) 136:e70021

GLP-1 has multiple beneficial effects in cardiovascular diseases such as hypertension, myocardial ischemia, atherosclerosis, and heart failure

[DOI] [PubMed] [Google Scholar] 214.Li J-w, Yuan K, Shang S-c, Guo Y

My doctor chased me for like two years, and I was like, No Im afraid of it, I already have thyroid problems, she said

We want to hear if anything changes, for the better or worse

Current Guidelines and Real-World Evidence Current guidelines (ADA-2023, KIDGO-2022, and ESC-2023) recommend SGLT-2 inhibitors and GLP-1 receptor agonists as first-line therapies in type 2 diabetes patients with cardiovascular disease, chronic kidney disease, and heart failure